Another work in a CT26 murine colon carcinoma model also suggests that blockade of CCL2 (or macrophage chemoattractant protein-1, MCP-1) is sufficient to reduce circulating monocytes-derived TAMs in TME and has the ability to modestly alter tumor growth to treatment [111]. The gene discussed is CCL2; the disease is colon carcinoma.